Kura Oncology (KURA) Assets Average (2011 - 2026)

Kura Oncology (KURA) has 16 years of Assets Average data on file, last reported at $695.5 million in Q1 2026.

• Assets Average for Q1 2026 came in at $695.5 million, down 7.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $695.5 million (down 7.51% YoY), and the FY2025 annual result was $749.3 million, up 23.94% from the prior year.
• Assets Average held at $695.5 million in Q1 2026 per KURA's latest filing, from $693.9 million in the prior quarter.
• Over five years, Assets Average peaked at $752.0 million in Q1 2025 and troughed at $441.1 million in Q1 2023.
• A 5-year average of $554.9 million and a median of $501.4 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2025: Assets Average retreated 19.77% in 2022, then jumped 49.97% in 2025.
• A 5-year view of Assets Average shows it stood at $452.1 million in 2022, then increased by 2.04% to $461.4 million in 2023, then jumped by 34.28% to $619.5 million in 2024, then gained by 12.01% to $693.9 million in 2025, then rose by 0.23% to $695.5 million in 2026.
• Business Quant data shows KURA's Assets Average at $695.5 million in Q1 2026, $693.9 million in Q4 2025, and $665.9 million in Q3 2025.